Inventor · disambiguated record
Alina Baum
Also filed as: BAUM ALINA
9 granted patents·11 pending applications·269 citations·filing 2020–2024
86Inventor score
Top patents by PatentIndex Score
20 records- 0197US10975139B1Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragmentsREGENERON PHARMA·Filed 2020·Granted Apr 13, 2021·15 cites·20 claims
- 0297US10954289B1Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragmentsREGENERON PHARMA·Filed 2020·Granted Mar 23, 2021·28 cites·28 claims
- 0397US10787501B1Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragmentsREGENERON PHARMA·Filed 2020·Granted Sep 29, 2020·224 cites·20 claims
- 0493US11732030B2Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragmentsREGENERON PHARMA·Filed 2021·Granted Aug 22, 2023·2 cites·51 claims
- 0586US12251440B2Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragmentsREGENERON PHARMA·Filed 2023·Granted Mar 18, 2025·0 cites·16 claims
- 0674US2024343831A1Anti-tmprss2 antibodies and antigen-binding fragmentsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0772US2024083983A1Anti-hemagglutinin antibodies and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0869US12496470B2Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragmentsREGENERON PHARMA·Filed 2022·Granted Dec 16, 2025·0 cites·20 claims
- 0968US2024252601A1Ace2 fusion proteins and uses thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1067US11999799B2Anti-TMPRSS2 antibodies and antigen-binding fragmentsREGENERON PHARMA·Filed 2021·Granted Jun 4, 2024·0 cites·44 claims
- 1166US11773156B2Anti-hemagglutinin antibodies and methods of use thereofREGENERON PHARMA·Filed 2020·Granted Oct 3, 2023·0 cites·21 claims
- 1266US2024287162A1Multivalent anti-spike protein binding molecules and uses thereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1366US2024309072A1Multivalent anti-spike protein binding molecules and uses thereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1466US2024307512A1ACE2-IgM-Fc FUSION PROTEINS AND USES THEREOFREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1565US11752214B2Protein-antiviral compound conjugatesREGENERON PHARMA·Filed 2021·Granted Sep 12, 2023·0 cites·19 claims
- 1661US2025049006A1Non-human animals comprising humanized ace2 and tmprss lociC/O REGENERON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1760US2024316169A1Utilization of antibodies to shape antibody responses to an antigenREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1853US2024043504A1Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding FragmentsREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 1952US2023232796A1Non-human animals comprising a humanized ace2 locusREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 2049US2023149536A1Compositions for treating and/or preventing coronavirus infectionsVYRIAD INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alina Baum files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →